-
1تقرير
المؤلفون: Ionis Pharmaceuticals, Inc.
المصدر: An Open-label Phase 2 Study of ISIS 703802 (AKCEA-ANGPTL3-LRx) Administered Subcutaneously to Subjects With Familial Partial Lipodystrophy
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT03514420Test
-
2تقرير
المؤلفون: Ionis Pharmaceuticals, Inc.
المصدر: A Randomized, Double-Blind, Placebo-Controlled, With an Open Label Extension, Phase 2/3 Study of ISIS 304801 Administered Subcutaneously to Patients With Familial Partial Lipodystrophy
الوصول الحر: https://clinicaltrials.gov/ct2/show/NCT02527343Test